Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ugo Pastorino 6"'
Autor:
Silvia Valtorta* 1, 2, Massimo Moro* 3, Giovanna Prisinzano 1, 4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3, Rosa Maria Moresco +2, 4 *Contributed equally to this work. +Contributed equally to this work.
Publikováno v:
The Journal of nuclear medicine (1978) 58 (2017): 42–47. doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta* 1,2, Massimo Moro* 3, Giovanna Prisinzano 1,4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2,4, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3 and Rosa Maria Moresco +2,4 *Contributed equally to this work. +Contributed equally to this work./titolo:Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response./doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978)/anno:2017/pagina_da:42/pagina_a:47/intervallo_pagine:42–47/volume:58
The Journal of nuclear medicine (1978. Online) (2016). doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta, Massimo Moro, Giovanna Prisinzano, Giulia Bertolini, Monica Tortoreto, Isabella Raccagni, Ugo Pastorino, Luca Roz, Gabriella Sozzi, and Rosa Maria Moresco/titolo:Metabolic evaluation of non-small cell lung cancer patient-derived xenografts models using [18F]FDG PET: potential tools for early therapy response/doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978. Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Silvia Valtorta* 1,2, Massimo Moro* 3, Giovanna Prisinzano 1,4, Giulia Bertolini 3, Monica Tortoreto 5, Isabella Raccagni 2,4, Ugo Pastorino 6, Luca Roz 3, Gabriella Sozzi +3 and Rosa Maria Moresco +2,4 *Contributed equally to this work. +Contributed equally to this work./titolo:Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response./doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978)/anno:2017/pagina_da:42/pagina_a:47/intervallo_pagine:42–47/volume:58
The Journal of nuclear medicine (1978. Online) (2016). doi:10.2967/jnumed.116.176404
info:cnr-pdr/source/autori:Silvia Valtorta, Massimo Moro, Giovanna Prisinzano, Giulia Bertolini, Monica Tortoreto, Isabella Raccagni, Ugo Pastorino, Luca Roz, Gabriella Sozzi, and Rosa Maria Moresco/titolo:Metabolic evaluation of non-small cell lung cancer patient-derived xenografts models using [18F]FDG PET: potential tools for early therapy response/doi:10.2967%2Fjnumed.116.176404/rivista:The Journal of nuclear medicine (1978. Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
PURPOSE: Lung cancer heterogeneity makes response to therapy extremely hard to predict. Patient-derived xenografts (PDXs) represent a reliable preclinical model that closely recapitulates the main characteristics of the primary tumor and could repres
Publikováno v:
OncoTarget.
// Roberto Lugo 1 , Marta Gabasa 1 , Francesca Andriani 2 , Marta Puig 1, 3 , Federica Facchinetti 2 , Josep Ramirez 4 , Abel Gomez-Caro 5 , Ugo Pastorino 6 , Gemma Fuster 6, 7 , Isaac Almendros 1 , Pere Gascon 3, 7 , Albert Davalos 8 , Noemi Reguart
The previous volumes in this series on soft tissue sarcomas highlighted the importance of the multidisciplinary approach to treatment, and this focus is continued in the present volume. Proper diagnosis and staging remain the cornerstone of the treat